Patient-Reported Outcome Consortium Working Groups
Asthma
- Actelion Pharmaceuticals Ltd.
- Amgen Inc.
- AstraZeneca Pharmaceuticals
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Forest Research Institute
- GlaxoSmithKline
- Ironwood Pharmaceuticals, Inc.
- Janssen Pharmaceutical Companies of Johnson & Johnson
- Merck Sharp & Dohme
- Novartis Pharmaceutical Corporation
- Roche
Cognition (mild cognitive impairment)
- Abbott Laboratories
- AstraZeneca Pharmaceuticals
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Bristol-Myers Squibb Company
- Eisai
- Janssen Pharmaceutical Companies of Johnson & Johnson
- Merck Sharp & Dohme
- Novartis Pharmaceutical Corporation
- Pfizer, Inc.
- Roche
Depression
- Abbott Laboratories
- Bristol-Myers Squibb
- Eli Lilly & Company
- Forest Research Institute
- Janssen Global Services, LLC
- Pfizer, Inc.
- Shire Corp.
- Sunovion Pharmaceuticals Inc.
Functional Dyspepsia
- Forest Research Institute
- Ironwood Pharmaceuticals, Inc.
- Shire Corp.
Irritable Bowel Syndrome
- Forest Research Institute
- Ironwood Pharmaceuticals, Inc.
- Takeda Pharmaceuticals US
Non-Small Cell Lung Cancer
- Abbott Laboratories
- Boehringer Ingelheim
- Bristol-Myers Squibb Company
- Daiichi Sankyo, Inc.
- Eli Lilly & Company
- Merck
- Roche
Rheumatoid Arthritis
- Boehringer Ingelheim
- Eli Lilly & Company
- GlaxoSmithKline
- Janssen Pharmaceutical Companies of Johnson & Johnson
- Merck Sharp & Dohme
- Novo Nordisk, Inc.
- Roche
- UCB Pharma Ltd.